Market Cap (In USD)
8.44 Million
Revenue (In USD)
82.12 Thousand
Net Income (In USD)
-14.17 Million
Avg. Volume
23.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0061-0.0165
- PE
- -0.03
- EPS
- -0.18
- Beta Value
- 3.965
- ISIN
- CA28660W2004
- CUSIP
- -
- CIK
- -
- Shares
- 1383996159.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Ferras Zalt
- Employee Count
- -
- Website
- https://www.elixxer.com
- Ipo Date
- 2017-12-14
- Details
- Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.
More Stocks
-
DSDVFDSV A/S
DSDVF
-
CNVCFBioHarvest Sciences Inc.
CNVCF
-
DEL
-
6928
-
8044PChome Online Inc.
8044
-
0030
-
SCYXSCYNEXIS, Inc.
SCYX
-
MCHP